RPC P10, Inc. Insider Trading

Director Stewart Robert B Jr bought 7,000 shares of RPC at $7.27; stock down 33.6% from 52-week high, -12.9% in 30 days.

Director Stewart Robert B Jr purchased 7,000 shares on 2026-03-31 at $7.27, increasing his holdings by 4.7% to 156,525 shares total. The purchase occurred as RPC trades -33.6% below its 52-week high of $10.58 and has declined 12.9% over the past 30 days. The company reported a P/E of 39.06 with recent quarterly revenue of $75.9M and net income of $2.1M, though annual revenue growth stands at only +0.3%. The director's prior open-market activity shows a mixed record: his 2 prior RPC purchases (on 2026-02-24 and 2026-02-19) each recorded 30-day losses of -11.4% and -12.5% respectively, and his cross-ticker track record of 2 prior buys averaged a -11.9% 30-day return. This transaction adds to an emerging pattern of purchases during recent price weakness, though the insider's timing accuracy on prior similar trades at this ticker and across holdings does not demonstrate reliable foresight.

Director McCoy bought 70,000 RPC shares at $7.37; holdings up 35.0% to 270.1K shares

McCoy David M., a Director of Ridgepost Capital, purchased 70,000 shares at $7.37 on 2026-03-23, increasing his holdings by 35.0% from 200.1K to 270.1K shares. The current price of $7.03 sits 33.6% below the 52-week high of $10.58, and the stock has declined 12.6% over the last 30 days. Across his cross-ticker track record, McCoy's 5 prior buys averaged +6.7% returns over 30 days with a 40% win rate, suggesting mixed timing accuracy on purchases. The company's fundamentals show modest revenue of $75.9M with minimal annual growth of +0.3%, and a notably elevated P/E ratio of 39.06 relative to net income of $2.1M, warranting deeper examination of valuation and profitability drivers.

Charles K. Huebner Trust purchases 32,500 shares across 2 transactions at blended $8.15, raising stake 20.8% to 188,554 shares

Charles K. Huebner Trust acquired 32,500 shares (32.5K shares) in two separate transactions totaling $264,975.00, purchasing 20,000 shares at $8.68 on 2026-02-19 and 12,500 shares at $7.31 on 2026-03-12, with a blended average price of $8.15. The purchases increased the trust's post-transaction holdings to 188,554 shares, representing a net change of +20.8% relative to pre-transaction holdings of 156,054 shares. With current market price at $7.32 as of 2026-03-16, the second tranche was transacted above current price while the first was transacted significantly above current price, within the context of a recent listing (23 trading days). The P/E ratio of 40.67 combined with revenue growth of +0.3% year-over-year presents a valuation backdrop worth noting for ongoing observation of the position and company fundamentals.

Director Robert B Stewart Jr buys 5,000 shares of RPC at $8.27 on 2026-02-24, 11 days after listing.

Stewart, a director at Ridgepost Capital, purchased 5,000 shares at $8.27, bringing his total holdings to 149,525 shares and representing a 3.5% increase in his position. This discretionary buy occurs just 11 trading days after the company's IPO, when investors are still forming views on valuation and fundamentals. The company's financials show $75.9M in quarterly revenue with +22.6% annual growth and a P/E of 48.76, indicating a fast-growing but richly-valued profile at listing. The proximity to IPO and the current price of $8.29 (versus the transaction price of $8.27) provides limited context for assessing price timing in this recent-listing environment.

Director Stewart Robert B Jr bought 10,000 shares of RPC at $8.65 on 2026-02-19, raising holdings to 144.5K shares

Director Stewart Robert B Jr purchased 10,000 shares at $8.65, expanding his stake by 7.4% to 144.5K shares just 8 trading days after the company's IPO. The transaction occurred when the stock traded above its current $8.04 level, and Ridgepost Capital reported $75.9M in quarterly revenue with annual growth of +22.6% and profitability ($2.1M net income), though the elevated P/E of 47.29 reflects early-stage pricing dynamics. This insider buy during the initial trading window, combined with meaningful share accumulation by a board member, provides a real-time signal of management's assessment of value in the newly public security. Investors should monitor whether this purchase pattern repeats among other insiders and how it aligns with forward earnings delivery given the steep valuation multiple.

Director Poston sells 107,976 shares in 3 tranches for $1.3M; post-sale holds 2.42M shares (-4.3%)

Poston Edwin A. (Director) executed 3 separate open-market sales totaling 107,976 shares for $1,309,897.26 across September 18–22, 2025, at a blended average price of $12.13. His post-transaction holdings of 2,423,531 shares represent a -4.3% reduction from pre-transaction levels. The sales occurred as the stock declined 6.9% over the prior 30 days, moving from near its 52-week high of $14.17 toward the current price of $11.87 (-16.2% from peak). Across his cross-ticker open-market history, Poston's prior sells show a 100.00% well-timed rate at the 90-day mark, though his same-ticker history at PX shows mixed recent results (one prior 90-day sale was -13.6%, well-timed; one 30-day outcome was -6.5%). The company's fundamentals show strong growth (annual revenue +22.6%) and profitability ($3.4M net income on $72.7M revenue), though the elevated P/E of 69.82 reflects market pricing in substantial future expectations.

Director Poston sells 97,024 shares across 2 transactions at $12.72 avg; 90-day timing strong but current price $12.47 below sale prices

Edwin A. Poston executed 2 separate sales totaling 97,024 shares for $1,233,982.98 at blended average price $12.72. His stake in P10, Inc. declined 3.6% to 2,576,507 shares post-transaction. Against his cross-ticker track record, his prior sell at this ticker on 2025-02-20 delivered 90-day return of -13.6%, confirming the insider's history of selling ahead of declines (100.00% well-timed rate at 90-day mark). However, the current stock price of $12.47 has not yet fallen below his execution prices of $12.80 and $12.50, and the 30-day change shows +1.3% movement upward since the August sales. The company's revenue growth of +22.6% year-over-year and elevated P/E of 73.35 provide context for valuation and investor expectations.

CFO Luke Sarsfield purchases 5,000 PX shares at $9.87; stock down 30.2% from 52-week high of $14.17

Sarsfield Luke A. III purchased 5,000 shares at $9.87 on 2025-06-09, increasing his holdings from 183,134 shares to 188,134 shares. The transaction occurred as PX trades at $9.89, approximately 30.2% below its 52-week high of $14.17 and down 15.2% over the past 30 days. The company reported latest-quarter revenue of $67,667,000.00 with annual revenue growth of +22.6%, though the P/E ratio of 58.18 remains elevated relative to near-term earnings of $4,522,000.00. This insider acquisition at a depressed intra-year price level merits monitoring to assess whether the purchase reflects informational advantage or simply routine portfolio activity.

HOOD MARK C acquired 5,000 shares of PX at $9.81; stock down 30.2% from 52-week high of $14.17

HOOD MARK C purchased 5,000 shares at $9.81 on 2025-06-09, increasing holdings by 6.0% to 87,735 shares. The purchase occurs with the stock trading at $9.89 (current price), which is 30.2% below the 52-week high of $14.17 and down 15.2% over the past 30 days. Despite recent weakness, the underlying business shows solid fundamentals with annual revenue growth of 22.6% and a net income of $4.5M on quarterly revenue of $67.7M, though the company trades at a P/E of 58.18 reflecting higher valuation expectations. The transaction appears discretionary and open-market, occurring after a period of stock price decline and at a discount to recent highs, though without visibility into the insider's broader transaction history at this ticker, the full context for this addition remains incomplete.

10% owner Mel Williams sold 200,000 shares ($2.4M) across 3 trades at $12.07–$12.14 on May 12–14, 2025

Mel Williams, a 10% owner, executed 3 separate sales totaling 200,000 shares for $2,417,602.45 at a blended average price of $12.09 across May 12–14. The sales reduced his holdings from 4.29M shares to 4.09M shares, a -4.7% reduction in his stake. The company showed strong recent fundamentals: quarterly revenue of $67.7M, net income of $4.5M, and annual revenue growth of +22.6%. However, the P/E ratio of 71.29 is elevated relative to profitability, and the stock is trading 14.5% below its 52-week high of $14.17 despite a +12.0% move in the 30-day window. The filing does not provide disclosure of plan or scheduling flags, so the timing and motivation of these sales remain unspecified by the data.